Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology. [electronic resource]
Producer: 20190715Description: 345-351 p. digitalISSN:- 1752-8062
- Antineoplastic Agents, Immunological -- administration & dosage
- Clinical Trials, Phase II as Topic -- standards
- Clinical Trials, Phase III as Topic -- standards
- Dose-Response Relationship, Drug
- Drug Development -- standards
- Humans
- Maximum Tolerated Dose
- Medical Oncology -- standards
- Neoplasms -- drug therapy
- United States
- United States Food and Drug Administration -- standards
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
There are no comments on this title.
Log in to your account to post a comment.